CN Patent

CN111587114A — 用于调节人免疫应答的咪唑并嘧啶的用途

Assigned to Boston Childrens Hospital · Expires 2020-08-25 · 6y expired

What this patent protects

本文中提供了咪唑并嘧啶化合物，其用于增强人免疫应答和/或用作疫苗中的佐剂。

USPTO Abstract

本文中提供了咪唑并嘧啶化合物，其用于增强人免疫应答和/或用作疫苗中的佐剂。

Drugs covered by this patent

capmatinib-hydrochloride (CAPMATINIB HYDROCHLORIDE)

Patent Metadata

Patent number: CN111587114A
Jurisdiction: CN
Classification: —
Expires: 2020-08-25
Drug substance claim: No
Drug product claim: No
Assignee: Boston Childrens Hospital
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.